Clinical trial Recruiting at 1 site Observational Ages 18 to 70

Superpulse thulium fiber versus holmium:YAG laser for breaking kidney and upper ureter stones during ureteroscopy

Official title: Comparison of Super Pulse Fiber Thulium Laser and Holmium Laser Lithotripsy Under Ureteroscopy

Run by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · NCT06667557 · Data updated 2026-11-12

This trial tests whether the superpulse thulium fiber laser works better than the holmium:YAG laser for adults (18–70) having ureteroscopy to break 6–20 mm kidney or upper ureter stones.

More Kidney Calculi trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment136 (estimated)
SponsorShanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedJanuary 20, 2025
Main results expectedOctober 20, 2027
Study endsOctober 20, 2028
Registry record updatedJanuary 21, 2026
Trial IDNCT06667557 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with kidney or upper ureter stones measuring 6–20 mm who are scheduled for flexible ureteroscopy under general anesthesia.

Probably not a fit

Patients with a single kidney, untreated urinary infection, major urinary tract anatomic abnormalities, prior urinary diversion or transplant, or severe comorbid conditions are excluded and unlikely to benefit from joining this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized controlled trial will enroll 136 adults (18–70) with CT-confirmed kidney or upper ureter stones 6–20 mm and randomize them 1:1 to flexible ureteroscopy (FURS) using either superpulse thulium fiber laser (sTFL) or holmium:YAG laser (Ho:YAG). Procedures are performed under general anesthesia and the primary outcome is stone-free rate at 3 months, defined as residual fragments <2 mm on CT. Secondary outcomes include operation time, intra- and postoperative complications graded by Clavien–Dindo, surgeon visual experience, and stone recurrence at 6 months. Participants will be monitored closely for adverse events throughout the study period.

Why it matters

Potential benefit: If successful, sTFL could increase stone-free rates and shorten operating time, reducing the need for repeat procedures and lowering complication rates.

How similar studies have gone: Early clinical series and smaller randomized trials have shown promising improvements in dusting efficiency and operative time with sTFL, but large multicenter randomized evidence is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years old
* Diagnosis of kidney stones and/or upper ureteral stones with stone diameter ≥6mm and ≤20mm
* Plan to undergo fURS lithotripsy
* General anesthesia to complete the operation
* The latest urine culture before surgery is negative
* Signed and dated informed consent indicating that the patient or his or her legal representative has been fully informed about the study and has consented to participate

Exclusion Criteria:

* Isolated kidney
* Previous history of kidney transplantation or urinary diversion surgery
* Congenital malformations of urinary system
* Abnormal coagulation mechanism due to blood system diseases, liver diseases, etc.
* Severe heart or lung disease, malignancy and immune deficiency status
* Neurogenic bladder
* Failure to provide informed consent
* Have an untreated urinary tract infection
* The presence of known anatomic abnormalities (such as ureteral stenosis), urothelial tumors, or stones that can be removed directly without the use of laser lithotripsy
* Pregnant women
* In cases where the stone cannot be reached with a bendable negative pressure suction sheath, or in cases where the stone cannot be reached with a conventional sheath or the pyeloureteral junction
* Surgical completion under epidural anesthesia or lumbar anesthesia
* Recurrent stones due to genetic metabolic diseases

Where it's running

  • Shanghai General Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Yi Shao — Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
  • Study coordinator: Ruixuan Zhu
  • Email: luluzhu2023@qq.com
  • Phone: +86 13780820139

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.